 |
|
 |
| |||||||||||||||||||||||||
|
 | ||||||||||
| | | | | ||||||
  ActimmuneŽ is indicated for chronic granulomatous disease (CGD) and severe, malignant osteopetrosis |  |
 View Development Pipeline
ITMN: NSDQ Price:
Change:
Date:
Time:
| |
 
| ||||||
|
|
|
|
|
| |||||||||||||||||||||||||
|
| ||||||||||
| | | | | ||||||
|
ActimmuneŽ is indicated for chronic granulomatous disease (CGD) and severe, malignant osteopetrosis | |
View Development Pipeline
ITMN: NSDQ Price:
Change:
Date:
Time:
| |
| ||||||
|
|
 | ||
| | |
 | | Corporate Overview |
 | ||
| | Executive Management Team |
| ||
| | Board of Directors |
| ||
| | Code of Business Conduct and Ethics |
| ||
| | Corporate Governance |
| ||